[1] |
ZHANG Lei, XIAO Xingpeng, DING Huang .
Silencing ZKSCAN3 gene expression aggravates lung injury induced by LPS in mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 164-170.
|
[2] |
TAO Chengjing, LIU Shourong, CHENG Xiaoxian, HU Jiannv, BAI Xiuli, ZHANG Suying, ZHAO Chun, ZUO Zhongbao.
Effects of different postpartum withdrawal time of tenofovir on hepatitis B virus markers, virology and biochemical indexes
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(10): 1146-1152.
|
[3] |
LUO Shengyong, JIA Dewu, LI Xiaoyi, DAI Xiangrong.
Study on the protective mechanism of anti-platelet thrombolysin against cerebral ischemia reperfusion injury in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(10): 1109-1115.
|
[4] |
HUO Na, LU Haiying, WANG Guiqiang, HUANG Mingjie, WU Chihong, LIN Xiaohong.
Effects of nucleos(t)ide analogues on renal function in patients with chronic hepatitis B
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(9): 1029-1034.
|
[5] |
QIAN Su-bo, CHEN Mu, SHEN Hai-bo, QI Jun.
Effects of shRNA targeting IGF2 gene on the growth and cell cycle of human bladder cancer cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(11): 1233-1237.
|
[6] |
MO Hong-ying, JIANG Yong-nan, LI Yi-min, LAI Le, XIAO Zheng-lun.
Effect of MIF siRNA on the expression of Toll-like receptors and down stream signaling components in A549 cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(4): 382-387.
|
[7] |
TANG Yu-yan, LI Dan, YU Yong-sheng.
The advances of plasmacytoid dendritic cells (pDCs) in chronic hepatitis B
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(9): 1062-1066.
|
[8] |
YU Yong-sheng, WU Hao, TANG Zheng-hao, ZANG Guo-qing.
Effect of silencing CTLA4 with siRNA on the Th1/Th2 cytokines in peripheral blood of chronic hepatitis B patient
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(5): 553-557.
|
[9] |
JIANG Yong-nan, MO Hong-ying, CHEN Jian-hai.
Protective effect of MIF siRNA mediated by lipid microbubbles on acute lung injury in mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(7): 737-741.
|
[10] |
ZENG Yan-mei, ZHANG Si-quan, LOU Guo-qiang, CHEN Jun, SHI Jun-ping, LIU Shou-rong, HUANG Jin-song.
Clinical study on preventing babby infections in uterine from hepatitis B virus with telbivudine
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(4): 443-445.
|
[11] |
SUN Hua, ZHAO Ya-nan, GUO Yi-yun, LI Xiang-hong, YANG Jing-jing, MAO Guo-guang, XIE Hai-tang.
Determination of lamivudine in human plasma by RP-HPLC and its application to bioequivalence research
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(2): 185-189.
|
[12] |
PENG Guan-qing, ZHANG Chang, LIU Xue-feng.
Clinical character of patients relapsed after withdrawal with lamivudine therapy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(10): 1166-1169.
|
[13] |
LIU Xue-ni, PAN Qing-chun, ZANG Guo-qing, YU Yong-sheng.
Structure of hepatitis B virus core protein and disablement in the hepatitis B antiviral therapy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(10): 1170-1173.
|
[14] |
LU Hai-ying, ZENG Zheng, TIAN Di, CUI Jian-jun, TIAN Guo-bao, TIAN Xiu-lan, YU Min, QIN Xiao-qin.
Clinical significance of alpha-fetoprotein detection in HBV infectious related diseases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(8): 939-942.
|
[15] |
LI Wen-li, WU Shi-pin.
Efficacy of adefovir dipivoxil in treating patients with hepatitis B resistant to lamivudine
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(7): 832-834.
|